Nirvana Life Sciences Inc. (CSE:NIRV)

Nirvana Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	0	0	0	0.01	0.04	0.62
Cash & Short-Term Investments	0	0	0	0.01	0.04	0.62
Cash Growth	-36.56%	39.94%	-84.69%	-65.08%	-94.27%	-
Other Receivables	0.02	0.02	0.02	0.02	0.01	0.01
Receivables	0.02	0.02	0.02	0.02	0.01	0.11
Prepaid Expenses	-	-	-	0.04	0.09	0.04
Total Current Assets	0.02	0.02	0.02	0.07	0.14	0.77
Property, Plant & Equipment	-	-	-	-	0.34	0.43
Total Assets	0.02	0.02	0.02	0.07	0.49	1.2
Accounts Payable	0.2	0.25	0.18	0.17	0.07	0.01
Accrued Expenses	0.24	1.15	0.94	0.78	0.57	0.01
Short-Term Debt	0.1	0.1	0.03	0.06	-	-
Other Current Liabilities	-	0.01	0.01	0.01	0.01	0
Total Current Liabilities	0.55	1.51	1.16	1.01	0.65	0.02
Total Liabilities	0.55	1.51	1.16	1.01	0.65	0.02
Common Stock	7.89	6.92	6.92	6.38	5.98	1.81
Retained Earnings	-8.98	-8.98	-8.62	-7.75	-6.26	-0.61
Comprehensive Income & Other	0.57	0.57	0.56	0.43	0.11	-0.01
Total Common Equity	-0.52	-1.48	-1.13	-0.94	-0.16	1.18
Minority Interest	-0	-0	-0	-0	0	-
Shareholders' Equity	-0.53	-1.49	-1.14	-0.94	-0.16	1.18
Total Liabilities & Equity	0.02	0.02	0.02	0.07	0.49	1.2
Total Debt	0.1	0.1	0.03	0.06	-	-
Net Cash (Debt)	-0.1	-0.1	-0.03	-0.05	0.04	0.62
Net Cash Growth	-	-	-	-	-94.27%	-
Net Cash Per Share	-0.01	-0.02	-0.01	-0.01	0.01	0.18
Filing Date Shares Outstanding	22.82	4.82	4.82	4.82	3.4	3.98
Total Common Shares Outstanding	22.82	4.82	4.82	3.4	3.3	3.98
Working Capital	-0.53	-1.49	-1.14	-0.94	-0.5	0.75
Book Value Per Share	-0.02	-0.31	-0.23	-0.28	-0.05	0.30
Tangible Book Value	-0.52	-1.48	-1.13	-0.94	-0.16	1.18
Tangible Book Value Per Share	-0.02	-0.31	-0.23	-0.28	-0.05	0.30
Machinery	-	-	-	-	0.46	0.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.